FindTrial
Sign In

Comparison of Paired Maternal and Fetal Metabolomics in Preeclampsia versus Fetal Growth Restriction

Comparative Metabolomic Profiling of Paired Maternal and Fetal Samples in Preeclampsia and Fetal Growth Restriction - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108792
Enrollment
200
Registered
2026-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O11- -2146826259

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

COUNCIL OF SCIENCE AND TECHNOLOGY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women with singleton pregnancy attending antenatal OPD and delivering at department of Obstetrics and Gynaecology Group A- 50 normotensive pregnant women with baby having birth weight appropriate for gestational age (control group) Group B- 50 normotensive pregnant women having FGR babies Group C- 50 pregnant women with Preeclampsia without FGR Group D-50 pregnant women having both PE and FGR

Exclusion criteria

Exclusion criteria: Chronic hypertension Chronic renal disease Autoimmune disorder Type 1/ 2 Diabetes mellitus Not willing to participate

Design outcomes

Primary

MeasureTime frame
1.To study the metabolomic profile of paired maternal and fetal samples in PE and FGR 2.To compare paired maternal and fetal metabolomics in FGR fetuses with preeclampsia and without PreeclampsiTimepoint: 3 years—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDR MANJU LATA VERMA

KING GEORGES MEDICAL UNIVERSITY

gaganmlv@gmail.com7007823748

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026